Summit Biolabs Announces Changes to its Board of Directors

Summit Biolabs, a commercial-stage molecular diagnostics company harnessing the power of direct-to-PCR technology to transform the detection of infectious diseases, today announced the appointment of ...

Learn More

PharmaJet partner Zydus Cadila announces COVID-19 vaccine expansion plan to multiple countries with Korean firm

PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila, is partnering with Enzychem Lifesciences to manufacture their COVID-19 plasmid DNA...

Learn More

LivaNova holds ribbon-cutting for $10.5 million sterilization facility in Arvada

The Arvada manufacturing facility of LivaNova — a global medical device producer -unveiled a state-of-the-art $10.5 million sterilization facility on Dec. 15 that will allow the company to sterilize h...

Learn More

PharmStars Announces 2021 Accelerator Graduates, Includes CBSA Member SmartTab

12 digital health startups have successfully completed PharmStars’ inaugural 10-week pharma-focused accelerator program. PharmStars, the pharma-focused accelerator for digital health startups, is deli...

Learn More

Inscipta Named in Colorado's Top 10 Tech and Startup Fundings of 2021

There have been more than a dozen deals north of $100 million in 2021, including three over $200 million in the technology space. CBSA member and Boulder-based Inscripta Inc., a digital genome enginee...

Learn More

Colorado Coalition Selected as Finalist for Economic Development Administration’s (EDA) Build Back Better Regional Challenge

Colorado Coalition will Compete for up to $100 Million to Supercharge Economy through Eight Projects The Colorado Coalition, the regional stakeholder group led by Innosphere Ventures in part...

Learn More

PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next generation DNA-based COVID-19 vaccine candidates

Vaccines to be delivered via needle-free jet injection GOLDEN, Colo. — December 14, 2021 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that one of...

Learn More

Biodesix Partners with Spesana to Streamline Digital Access to Molecular Diagnostics for Precision Medicine in Lung Cancer

 Spesana, the developer of a novel electronic operating system to unify EMRs, and Biodesix Inc. (NSDQ: BDSX), a leading data-driven diagnostic solutions company with a focus in lung dis...

Learn More

Proov® to Expand Women’s Hormone Health Solutions to Advance Women’s Health and Offer More Accessible Care with $9.7M Series A Funding

Proov, creator of the first and only FDA-cleared PdG-testing kit to educate and empower women about their reproductive health, announces today it raised $9.7 million in Series A Funding. The round was...

Learn More

Genapsys Selects Colorado for Manufacturing and R&D Expansion, Brings 240 new jobs to Colorado

Colorado continues to emerge as a bioscience hub. Genapsys, a life science company, has announced plans to open a second location in Westminster bringing approximately 240 new jobs to Colorado.  Genap...

Learn More